共 226 条
[1]
Haylen BT(2010)An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction Int Urogynecol J 21 5-26
[2]
de Ridder D(2014)Economic burden of urgency urinary incontinence in the United States: a systematic review J Manag Care Pharm 20 130-140
[3]
Freeman RM(2011)National community prevalence of overactive bladder in the United States stratified by sex and age Urology 77 1081-1087
[4]
Swift SE(2012)Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline J Urol 118 2455-2463
[5]
Berghmans B(2015)Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment J Urol 193 1572-1580
[6]
Lee J(2012)Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults Cochrane Database Syst Rev 12 CD003193-1774
[7]
Monga A(2012)Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience BJU Int 110 1767-1432
[8]
Petri E(2015)Comparative effectiveness of anticholinergic therapy for overactive bladder: a systematic review and meta-analysis Obstet Gynecol 125 1423-407
[9]
Rizk DE(2015)Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study JAMA Intern Med 175 401-30
[10]
Sand PK(2014)Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability Neurourol Urodyn 33 17-30249